47 results
424B2
NVTAQ
Invitae Corp
10 Aug 23
Prospectus for primary offering
4:01pm
of the COVID-19 pandemic on our business and the success of any measures we have taken or may take in the future in response thereto; risks associated … and measures taken by government authorities in response to the COVID-19 pandemic; our ability to obtain required regulatory approvals for our tests
POS AM
NVTAQ
Invitae Corp
9 Aug 23
Prospectus update (post-effective amendment)
9:20am
: the effect of the COVID-19 pandemic on our business and the success of any measures we have taken or may take in the future in response thereto; risks … and Drug Administration and measures taken by government authorities in response to the COVID-19 pandemic; our ability to obtain required regulatory
PRE 14A
wk96o9efwm 0h9
4 Apr 22
Preliminary proxy
4:15pm
424B5
lhxxtxmo0836benek bl
2 Mar 22
Prospectus supplement for primary offering
8:24am
8-K
EX-99.1
jrnjt
11 Jan 22
Invitae Reports Preliminary 2021 Revenue of More Than $458 Million and Billable Volume of More Than 1.16 Million
4:20pm
424B5
by743b
4 May 21
Prospectus supplement for primary offering
5:10pm
8-K
EX-10.1
7i8zlvw i8j3sr
23 Apr 21
Entry into a Material Definitive Agreement
5:25pm